Long Term of Follow-Up of Melanoma-Associated Retinopathy: A Case Report
MAR can be presented as the first sign of melanoma relapse. This case underscores MAR's potential for recurrence despite durable melanoma remission and highlights intravitreal dexamethasone as an effective long-term therapy. The absence of autoantibodies and late flares challenges current diagnostic paradigms, emphasizing ERG's critical role. Proactive ophthalmologic surveillance and individualized local therapy canpreserve vision in this underrecognized condition.
Authors
- Rachid Bouchikh-El Jarroudi (ORCID: https://orcid.org/0000-0002-7240-8246)
- Silvia Presas‐Rodríguez
- Sandra Gómez Sánchez
- Sofía España (ORCID: https://orcid.org/0000-0002-7825-0734)
- A. Blázquez-Albisú
- Estefanía Cobos Martín
- M. Sant Albors
- José Luis Manzano Monzo
Institutions
- Bellvitge University Hospital (ES)
- Institut Català d'Oncologia (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1080/09273948.2025.2600577
- Citations
- 1
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39